Odyssey Therapeutics, Inc., a clinical-stage biopharmaceutical company seeking to transform the standard of care for patients suffering from autoimmune and inflammatory diseases by developing...
GeneCentric Therapeutics, a company making precision medicine more precise through RNA-based diagnostics, announced the launch of its EXpressCTSM (Expression Signatures Through Circulating Tumor Signals) liquid biopsy platform...
Movemedical, the enterprise software platform for medical device inventory management, is pleased to announce a strategic investment partnership with Resurgens Technology Partners. This investment...
Disc Medicine, Inc, a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases,...
Here is Read Magazine’s Weekly Roundup of the top news from global markets. In this fast-paced world, breaking down information helps readers grasp the...
